An ongoing dialogue on HIV/AIDS, infectious diseases,
September 18th, 2009
Integrase Inhibitors: In Search of an Abbreviation
The alphabet soup that characterizes HIV therapeutics has always been one of its quirky challenges — for example, who could possibly know that 3TC, CBV, TZV, EPZ, and LAM all refer to drugs that are (or contain) lamivudine?
This drives our ID fellows nuts, and is certainly a strong deterrent to non-HIV specialists to learning the field.
(Maybe that’s why they pay us the big bucks… oh wait.)
And while we’ve grown comfortable with the abbreviations for the 3 oldest drug classes — NRTI, NNRTI, and PI — what are we to do with integrase inhibitors? Some candidates:
- “II” — sounds funny when you say it (“eye-eye”), and could be confused with “eleven” depending on the font
- “INSTI” — for “integrase strand transfer inhibitor”; I’ve already seen this one around a lot, but have also seen it written “InSTI” (lower-case n), which is hard to type
- “INI” — for “INtegrase Inhibitor”; same upper vs lower-case issue as “INSTI”, and saying “INI” always has an anatomic (especially umbilical) connotation to it
Still not sure where we’ll end up with this one, but I suspect “INSTI” will rule the day.
Categories: Health Care, HIV, Infectious Diseases, Misc
Tags: AIDS, Antiretroviral Rounds, ART, HAART, HIV, inhibitor, integrase, integrase inhibitors, nnrti
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
-
-
From the Blog — Most Recent Articles
- DOTS: Optimism Around a “Negative” Dalbavancin Trial October 10, 2025
- Update on Louie and One Interesting ID Fact October 3, 2025
- My Dog Louie, the Best Dog Ever, Is Seriously Ill September 26, 2025
- Two Drugs, Not Three: The DOLCE Study in Advanced HIV Disease September 19, 2025
- When Required Learning Modules Surprise You (In a Good Way) September 10, 2025
NEJM Journal Watch — Recent Infectious Disease Articles
- It's Not Always “Just the Flu”
- RSVpreF Vaccine's Effects on Severe Outcomes of RSV Infection
- Should Early Empirical Mold-Active Antifungals Be Given for Severe Influenza Pneumonia?
- Influenza Immunization for Inpatients with Advanced Heart Failure: Is it Beneficial?
- Another Option for RSV Prevention in Babies is Approved
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster